For the acute treatment of migraine in adults.
Important Safety Information
Prescribing Information
Stay Informed
Request a Representative
NOW AVAILABLE IN A 6-PACK
Trudhesa Direct

Hassle-free prescribing, at-home delivery, and $0 copay for eligible patients.*

Prescribing Trudhesa® is easy through digital pharmacies.

Request a Representative
Request a Representative

Prescribing Trudhesa® is easy through digital pharmacies.

1

E-Prescribe

Trudhesa is available to e-prescribe nationwide, through ASPN and PHIL pharmacies. The digital pharmacy will initiate and manage the prior authorization process.

Phone:      866-892-0038

Fax:            855-702-3626

ZIP Code:  07039

NCPDP:     3147863

Download ASPN Prescription Form

Phone:      855-588-0387, option 1

Fax:            855-494-1548

ZIP Code:  85260

NCPDP:     0364668

Download Phil Prescription Form

2

Enter the following information to minimize callbacks:
  • ICD-10 Code.
  • Prior medication code.
  • Patient’s mobile number—they’ll receive a text with next steps.†

3

Explain what’s next to your patient.

Give your patient a Trudhesa Direct Information Tear Sheet.

  • Patients will receive text messages to confirm their prescription.
  • Commercially insured eligible patients will be enrolled in the Trudhesa Direct Savings Program and will receive Trudhesa for as little as $0 per prescription.*
  • Trudhesa will be delivered directly to their home free of charge.

*Terms and Conditions: All eligible, commercially insured patients pay as little as $0 for Trudhesa® (dihydroergotamine mesylate). If Trudhesa is not covered by the patient’s commercial insurance plan, the patient pays as little as $0 for the first box (4 Pods) and as little as $0 for each additional box up to four (4) boxes per calendar year.

Restrictions: This offer is valid in the United States only. Offer is available if a patient has a prescription, is commercially insured and is 18 years or older. Offer is not valid for patients who use any state or federal government-funded healthcare program to cover a portion of medication costs, such as Medicare (including Medicare Part D), Medicaid, Medigap, TRICARE, Department of Defense (DOD), Veterans Administration (VA), patients who are cash-paying or where prohibited by law. By using this offer, the patient certifies that he or she will comply with any terms of his or her insurance plan. It is illegal to (or offer to) sell, purchase, or trade this offer. Void where prohibited by law. This program does not constitute health insurance. The parties reserve the right to rescind, revoke or amend this offer without notice at any time.

†Standard messaging rates apply.

References: 1. Trudhesa. Prescribing information. Impel Pharmaceuticals; 2021. 2. Shrewsbury SB, Hoekman J,  Jeleva M. Patient acceptability of a novel upper nasal delivery system for dihydroergotamine mesylate using the Precision Olfactory Delivery (POD®️) device – results from the open-label STOP 301 trial. Poster presented at: American Headache Society Virtual Annual Scientific Meeting, June 3-6, 2021. 3. Data on File. Impel Pharmaceuticals. 2020.